Dror Ortho-Design Q2 FY26 R&D expense drops 53% to $150,769

Reuters2026/07/30 21:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dror Ortho-Design posted a net loss of USD 1.26 million for the six months ended June 30, 2026, versus USD 1.34 million a year earlier.
Cash used in operations narrowed 28% to USD 709,019, leaving cash of USD 93,563 at June 30, 2026.
Research and development expense fell 52% to USD 269,179, due to decreased activities relating to software development.
Debt discount amortization more than doubled to USD 236,787, reflecting a higher amount of debt instruments issued after June 30, 2025.
The company had no revenue, flagged substantial doubt about going concern, and reiterated plans to spend about USD 1.5 million over 18 months on development and regulatory work.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dror Ortho-Design Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-083423), on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dror Ortho-Design Q2 FY26 R&D expense drops 53% to $150,769

You may also like

Crypto prices